Kaur, A. P. (2021). Inhibition of the p38 MAPK pathway in human CD1c+ Dendritic Cells enhances their function for cancer immunotherapy.
Chicago Style (17th ed.) CitationKaur, Aanchal Preet. Inhibition of the P38 MAPK Pathway in Human CD1c+ Dendritic Cells Enhances Their Function for Cancer Immunotherapy. 2021.
MLA (9th ed.) CitationKaur, Aanchal Preet. Inhibition of the P38 MAPK Pathway in Human CD1c+ Dendritic Cells Enhances Their Function for Cancer Immunotherapy. 2021.
Warning: These citations may not always be 100% accurate.